| Kathryn Vinson Deitch, NP | |
|
20 Wetstone, Irvine, CA 92604-3694 | |
| (949) 387-3904 | |
| Not Available |
| Full Name | Kathryn Vinson Deitch |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Women's Health |
| Location | 20 Wetstone, Irvine, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124235874 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LW0102X | Nurse Practitioner - Women's Health | RN273156 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kathryn Vinson Deitch, NP 20 Wetstone, Irvine, CA 92604-3694 Ph: () - | Kathryn Vinson Deitch, NP 20 Wetstone, Irvine, CA 92604-3694 Ph: (949) 387-3904 |
News Archive
Biologists at the California Institute of Technology have pinpointed molecular changes that helped allow the global spread of resistance to the antiviral medication Tamiflu (oseltamivir) among strains of the seasonal H1N1 flu virus.
A new Electronic Document Management System (EDMS) which is being introduced at Sheffield Teaching Hospitals NHS Foundation Trust will enable thousands of patient notes to be stored electronically, giving clinicians secure access to notes 24 hours a day, 365 days a year.
A multi-institutional, international team of scientists has discovered the genetic cause and biological mechanisms linked to a new human immunodeficiency. The study, which is published in Nature Immunology, also identifies a potential treatment.
The mounting U.S. drug price crisis can be contained and eventually reversed by separating drug discovery from drug marketing and by establishing a non-profit company to oversee funding for new medicines, according to two MIT experts on the pharmaceutical industry.
Sequella, Inc., a clinical-stage biopharmaceutical company focused on commercializing products to treat life-threatening infectious diseases, today announced that it amended an existing agreement with the National Institutes of Health (NIH) to significantly broaden the licensed therapeutic indications, or "field of use," for Sequella's lead drug candidate, SQ109.
› Verified 3 days ago
Katherine Lin Matsumoto, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 250 E Yale Loop Ste 204, Irvine, CA 92604 Phone: 949-732-3530 Fax: 949-732-3533 | |
Salma Essau Nawabi, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 14330 Culver Dr, Irvine, CA 92604 Phone: 949-559-8129 | |
Mrs. Amber Hardy Rickner, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1000 Fivepoint, Irvine, CA 92618 Phone: 949-671-4673 Fax: 949-671-4329 | |
Tina Thomas, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 19742 Macarthur Blvd Ste 101, Irvine, CA 92612 Phone: 949-955-0202 Fax: 949-955-0203 | |
Kelly Eguchi, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 17782 Cowan Ste A, Irvine, CA 92614 Phone: 949-722-7118 | |
Jude Legros Levasseur, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 19200 Von Karman Ave Ste 500, Irvine, CA 92612 Phone: 949-382-4776 | |
Mr. Jeskeith Brar, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4040 Barranca Pkwy Ste 260, Irvine, CA 92604 Phone: 424-284-2440 |